Novartis buys U.K. biotech firm, collaborates on Hep C treatment

The Manchester-based company specializes in treatments for infections usually acquired during hospital stays. Here's more about its founders. The Washington Post reports that Novartis will also collaborate with Human Genome Sciences on Albuferon, a treatment for Hepatitis C. -AMS